EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic and clinical features of patients with intrahepatic cholestasis caused by citrin deficiency

Wenjun Sun, Xiaoxi Zhang, Hang Su, Xiaoxia Wang, Fang Qin, Xiangling Gong, Bo Wang, Fei Yu

Journal of Pediatric Endocrinology and Metabolism · 2023

DOI: 10.1515/jpem-2022-0616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2023. Verfasst von Wenjun Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Genetic Metabolism in Children, Maternal and Child Health Hospital of Hubei Province, Wuhan, P.R. China. Hauptthemen laut MEDLINE: Citrullinemia, Cholestasis, Intrahepatic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Citrin deficiency (CD) is an autosomal recessive disease caused by mutations of the SLC25A13 gene, plasma bile acid profiles detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS) could be an efficient approach for early diagnosis of intrahepatic cholestasis. The aim of this study was to investigate the genetic testing and clinical characteristics of a series of patients with CD, and to analyse plasma bile acid profiles in CD patients.

Methods

We retrospectively analysed data from 14 patients (12 males and 2 females, age 1–18 months, mean 3.6 months) with CD between 2015 and 2021, including demographics, biochemical parameters, genetic test results, treatment, and clinical outcomes. In addition, 30 cases (15 males and 15 females, age 1–20 months, mean 3.8 months) with idiopathic cholestasis (IC) served as a control group. Plasma 15 bile acid profiles were compared between the CD and IC groups.

Results

Eight different mutations of the SLC25A13 gene were detected in the 14 patients diagnosed with CD, of which three novel variants of the SLC25A13 gene were investigated, the c.1043C>T (p.P348L) in exon11, the c.1216dupG (p.A406 Gfs*13) in exon12 and the c.135G>C (p.L45F) in exon3. More than half of the patients with CD had prolonged neonatal jaundice, which was associated with significantly higher alpha-fetoprotein (AFP) levels, hyperlactatemia and hypoglycemia. The majority of patients were ultimately self-limited. Only one patient developed liver failure and died at the age of 1 year due to abnormal coagulation function. In addition, the levels of glycochenodeoxycholic acid (GCDCA), taurocholate (TCA), and taurochenodeoxycholic acid (TCDCA) were significantly increased in the CD group compared with those in the IC group.

Conclusions

Three novel variants of the SLC25A13 gene were identified for the first time, providing a reliable molecular reference and expanding the SLC25A13 gene spectrum in patients with CD. Plasma bile acid profiles could be a potential biomarker for non-invasive early diagnosis of patients with intrahepatic cholestasis caused by CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CitrullinemiaCholestasis, IntrahepaticInfant, NewbornMaleFemaleHumansInfantRetrospective StudiesChromatography, LiquidTandem Mass SpectrometryMutationBile Acids and SaltsMitochondrial Membrane Transport ProteinsCalcium-Binding Proteins

Stichwörter der Autor:innen

SLC25A13citrin deficiencyliquid chromatography-tandem mass spectrometry (LC-MS/MS)novel mutationsplasma bile acid profiles

Substanzen

Bile Acids and SaltsMitochondrial Membrane Transport ProteinsCalcium-Binding ProteinsSLC25A13 protein, human

Autor:innen und Institutionen

  • Department of Endocrine Genetic Metabolism in Children, Maternal and Child Health Hospital of Hubei Province, Wuhan, P.R. China.
  • Department of Urology, Tian You Hospital Affiliated to Wuhan University of Science & Technology, Wuhan, P.R. China.
  • Medical Genetics Center, Maternal and Child Health Hospital of Hubei Province, Wuhan, P.R. China.

Zitieren

APA

Sun, W., Zhang, X., Su, H., Wang, X., Qin, F., Gong, X., Wang, B., & Yu, F. (2023). Genetic and clinical features of patients with intrahepatic cholestasis caused by citrin deficiency. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2022-0616

Vancouver

Sun W, Zhang X, Su H, Wang X, Qin F, Gong X, et al. Genetic and clinical features of patients with intrahepatic cholestasis caused by citrin deficiency. Journal of Pediatric Endocrinology and Metabolism. 2023. doi:10.1515/jpem-2022-0616

BibTeX
@article{Sun2023,
  author = {Sun, Wenjun and Zhang, Xiaoxi and Su, Hang and Wang, Xiaoxia and Qin, Fang and Gong, Xiangling and Wang, Bo and Yu, Fei},
  title = {Genetic and clinical features of patients with intrahepatic cholestasis caused by citrin deficiency},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  year = {2023},
  doi = {10.1515/jpem-2022-0616}
}
Kostenlos starten →